AIC
SIOX

Ameritas Investment Company’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Ameritas Investment Company’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5
Closed – – 1711
2020
Q1 		$0 Buy
+5
New +$18 ﹤0.01% 1857
2019
Q4 		– Sell
-5
Closed – – 1601
2019
Q3 		$0 Buy
+5
New +$34 ﹤0.01% 1670
2019
Q2 		– Sell
-6
Closed – – 933
2019
Q1 		$0 Sell
6
-157
-96% -$1.56K ﹤0.01% 1889
2018
Q4 		$1K Buy
+163
New +$2.35K ﹤0.01% 1475

Other funds holding SIOX

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameritas Investment Company's SIOX Position: Q2 2020 in Review

Ameritas Investment Company sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2020, closing a stake of 5 shares.

Ameritas Investment Company first reported a position in SIOX in Q4 2018 and held it in 4 quarters. The position peaked at $1K in Q4 2018. 40 funds tracked by Wall St. Rank hold SIOX as of Q2 2020.

  • Ameritas Investment Company reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Ameritas Investment Company sold 5 Sio Gene Therapies Inc. Common Stock shares in Q2 2020.
  • Ameritas Investment Company first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2018 and held it in 4 quarters.
  • Ameritas Investment Company's Sio Gene Therapies Inc. Common Stock position peaked at $1K in Q4 2018.
  • 40 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2020.

Based on Ameritas Investment Company's 13F filing for Q2 2020, filed 14 Aug 2020.